Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic MalignanciesSheng-Bin Peng, Victor H. Obungu, Xiaoyi Zhang et al.|PLoS ONE|2016Cited by 60
Abstract B134: The p38MAPK inhibitor LY2228820 dimesylate, in combination with cytotoxic agents, displays strong antitumor activity in human glioblastoma, multiple myeloma, and other mouse xenograft models.Susan E. Pratt, Louis F. Stancato, James J. Starling et al.|Molecular Cancer Therapeutics|2011Cited by 0